Development of perfluoroelastomer-based low-sorption microfluidic devices for drug metabolism and toxicity studies

[1] F. Zheng, F. Fu, Y. Cheng, C. Wang, Y. Zhao, Z. Gu, Organ-on-a-Chip Systems: Microengineering to

Biomimic Living Systems, Small 12(17) (2016) 2253-82.

[2] C.H. Beckwitt, A.M. Clark, S. Wheeler, D.L. Taylor, D.B. Stolz, L. Griffith, A. Wells, Liver 'organ on a

chip', Exp Cell Res 363(1) (2018) 15-25.

[3] K. Tan, P. Keegan, M. Rogers, M. Lu, J.R. Gosset, J. Charest, S.S. Bale, A high-throughput microfluidic

microphysiological system (PREDICT-96) to recapitulate hepatocyte function in dynamic, re-circulating

flow conditions, Lab Chip 19(9) (2019) 1556-1566.

[4] E. Moradi, S. Jalili-Firoozinezhad, M. Solati-Hashjin, Microfluidic organ-on-a-chip models of human

liver tissue, Acta biomaterialia 116 (2020) 67-83.

[5] M.W. Toepke, D.J. Beebe, PDMS absorption of small molecules and consequences in microfluidic

applications, Lab Chip 6(12) (2006) 1484-6.

[6] S.B. Campbell, Q. Wu, J. Yazbeck, C. Liu, S. Okhovatian, M. Radisic, Beyond Polydimethylsiloxane:

Alternative Materials for Fabrication of Organ-on-a-Chip Devices and Microphysiological Systems, ACS

Biomater Sci Eng 7(7) (2021) 2880-2899.

[7] R.Z. Xie, M.D. Evans, B. Bojarski, T.C. Hughes, G.Y. Chan, X. Nguyen, J.S. Wilkie, K.M. McLean, A.

Vannas, D.F. Sweeney, Two-year preclinical testing of perfluoropolyether polymer as a corneal inlay,

Investigative ophthalmology & visual science 47(2) (2006) 574-581.

[8] D. Liu, S. Jiao, J. Wei, X. Zhang, Y. Pei, Z. Pei, J. Li, Y. Du, Investigation of absorption, metabolism

and toxicity of ginsenosides compound K based on human organ chips, International Journal of

Pharmaceutics 587 (2020).

[9] Q. Ramadan, M. Zourob, Organ-on-a-chip engineering: Toward bridging the gap between lab and

industry, Biomicrofluidics 14(4) (2020) 041501.

[10] R. Jellali, T. Bricks, S. Jacques, M.J. Fleury, P. Paullier, F. Merlier, E. Leclerc, Long-term human

primary hepatocyte cultures in a microfluidic liver biochip show maintenance of mRNA levels and higher

drug metabolism compared with Petri cultures, Biopharm Drug Dispos 37(5) (2016) 264-75.

[11] N.S. Devaraju, M.A. Unger, Multilayer soft lithography of perfluoropolyether based elastomer for

microfluidic device fabrication, Lab Chip 11(11) (2011) 1962-7.

[12] B.H. Chueh, D. Huh, C.R. Kyrtsos, T. Houssin, N. Futai, S. Takayama, Leakage-free bonding of porous

membranes into layered microfluidic array systems, Anal Chem 79(9) (2007) 3504-8.

[13] B.L. Kreamer, J.L. Staecker, N. Sawada, G.L. Sattler, M.T. Hsia, H.C. Pitot, Use of a low-speed, isodensity percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations, In

Vitro Cell Dev Biol 22(4) (1986) 201-11.

[14] L. Kim, Y.-C. Toh, J. Voldman, H. Yu, A practical guide to microfluidic perfusion culture of adherent

mammalian cells, Lab on a Chip 7(6) (2007) 681-694.

[15] E.H. Gilglioni, J.C. Chang, S. Duijst, S. Go, A.A.A. Adam, R. Hoekstra, A.J. Verhoeven, E.L. IshiiIwamoto, R.P.J. Oude Elferink, Improved oxygenation dramatically alters metabolism and gene expression

in cultured primary mouse hepatocytes, Hepatol Commun 2(3) (2018) 299-312.

[16] U.M. Zanger, M. Schwab, Cytochrome P450 enzymes in drug metabolism: regulation of gene

expression, enzyme activities, and impact of genetic variation, Pharmacol Ther 138(1) (2013) 103-41.

32

[17] M. Tehranirokh, A.Z. Kouzani, P.S. Francis, J.R. Kanwar, Microfluidic devices for cell cultivation and

proliferation, Biomicrofluidics 7(5) (2013) 51502.

[18] D.J. Buckley, M. Berger, The swelling of polymer systems in solvents. II. Mathematics of diffusion,

Journal of Polymer Science 56(163) (1962) 175-188.

[19] D. Buckley, M. Berger, The swelling of polymer solvents. III. Sorption of liquids by elastomers,

Journal of Polymer Science 58(166) (1962) 1141-1152.

[20] Hansen, Charles, Hansen Solubility Parameters (A User¥"s Handbook, Second Edition) || Table A.2,

10.1201/9781420006834 (2007) 485-505.

[21] C.M. Hansen, The Universality of Solubility Parameter, Industrial & Engineering Chemistry Product

Research and Development 8(1) (1969).

[22] S.E. Bradley, F.J. Ingelfinger, G.P. Bradley, J.J. Curry, The Estimation of Hepatic Blood Flow in Man,

J Clin Invest 24(6) (1945) 890-7.

[23] P.F. Lalor, D.H. Adams, Adhesion of lymphocytes to hepatic endothelium, Mol Pathol 52(4) (1999)

214-9.

[24] Y. Tanaka, M. Yamato, T. Okano, T. Kitamori, K. Sato, Evaluation of effects of shear stress on

hepatocytes by a microchip-based system, Measurement Science and Technology 17(12) (2006) 3167-3170.

[25] A.W. Tilles, H. Baskaran, P. Roy, M.L. Yarmush, M. Toner, Effects of oxygenation and flow on the

viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor, Biotechnol

Bioeng 73(5) (2001) 379-89.

[26] Y. Kono, S. Yang, E.A. Roberts, Extended primary culture of human hepatocytes in a collagen gel

sandwich system, In Vitro Cell Dev Biol Anim 33(6) (1997) 467-72.

[27] J.C. Dunn, R.G. Tompkins, M.L. Yarmush, Long-term in vitro function of adult hepatocytes in a

collagen sandwich configuration, Biotechnol Prog 7(3) (1991) 237-45.

[28] A. Dash, M.B. Simmers, T.G. Deering, D.J. Berry, R.E. Feaver, N.E. Hastings, T.L. Pruett, E.L.

LeCluyse, B.R. Blackman, B.R. Wamhoff, Hemodynamic flow improves rat hepatocyte morphology,

function, and metabolic activity in vitro, Am J Physiol Cell Physiol 304(11) (2013) C1053-63.

[29] L.P.M. Duivenvoorde, J. Louisse, N.E.T. Pinckaers, T. Nguyen, M. van der Zande, Comparison of gene

expression and biotransformation activity of HepaRG cells under static and dynamic culture conditions, Sci

Rep 11(1) (2021) 10327.

[30] B. Vinci, C. Duret, S. Klieber, S. Gerbal-Chaloin, A. Sa-Cunha, S. Laporte, B. Suc, P. Maurel, A.

Ahluwalia, M. Daujat-Chavanieu, Modular bioreactor for primary human hepatocyte culture: medium flow

stimulates expression and activity of detoxification genes, Biotechnol J 6(5) (2011) 554-64.

[31] M.B. Esch, J.M. Prot, Y.I. Wang, P. Miller, J.R. Llamas-Vidales, B.A. Naughton, D.R. Applegate, M.L.

Shuler, Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow,

Lab Chip 15(10) (2015) 2269-77.

[32] X. Wang, X. Fang, J. Zhou, Z. Chen, B. Zhao, L. Xiao, A. Liu, Y.S. Li, J.Y. Shyy, Y. Guan, S. Chien,

N. Wang, Shear stress activation of nuclear receptor PXR in endothelial detoxification, Proc Natl Acad Sci

U S A 110(32) (2013) 13174-9.

[33] L. Burton, P. Scaife, S.W. Paine, H.R. Mellor, L. Abernethy, P. Littlewood, C. Rauch, Hydrostatic

pressure regulates CYP1A2 expression in human hepatocytes via a mechanosensitive aryl hydrocarbon

receptor-dependent pathway, Am J Physiol Cell Physiol 318(5) (2020) C889-C902.

[34] R. Baudoin, G. Alberto, A. Legendre, P. Paullier, M. Naudot, M.J. Fleury, S. Jacques, L. Griscom, E.

33

Leclerc, Investigation of expression and activity levels of primary rat hepatocyte detoxication genes under

various flow rates and cell densities in microfluidic biochips, Biotechnol Prog 30(2) (2014) 401-10.

[35] A. Bader, N. Fruhauf, M. Tiedge, M. Drinkgern, L. De Bartolo, J.T. Borlak, G. Steinhoff, A. Haverich,

Enhanced oxygen delivery reverses anaerobic metabolic states in prolonged sandwich rat hepatocyte culture,

Exp Cell Res 246(1) (1999) 221-32.

[36] P.P. Poyck, G. Mareels, R. Hoekstra, A.C. van Wijk, T.V. van der Hoeven, T.M. van Gulik, P.R.

Verdonck, R.A. Chamuleau, Enhanced oxygen availability improves liver-specific functions of the AMC

bioartificial liver, Artif Organs 32(2) (2008) 116-26.

[37] H.S. Frank, M.W. Evans, Free Volume and Entropy in Condensed Systems III. Entropy in Binary

Liquid Mixtures; Partial Molal Entropy in Dilute Solutions; Structure and Thermodynamics in Aqueous

Electrolytes, The Journal of Chemical Physics 13(11) (1945) 507-532.

[38] I.J. Onakpoya, C.J. Heneghan, J.K. Aronson, Post-marketing withdrawal of 462 medicinal products

because of adverse drug reactions: a systematic review of the world literature, BMC Med 14 (2016) 10.

[39] K. Fujimoto, H. Kishino, T. Yamoto, S. Manabe, A. Sanbuissho, In vitro cytotoxicity assay to evaluate

the toxicity of an electrophilic reactive metabolite using glutathione-depleted rat primary cultured

hepatocytes, Chemico-Biological Interactions 188(3) (2010) 404-411.

[40] D.F.G. Hendriks, T. Hurrell, J. Riede, M. van der Horst, S. Tuovinen, M. Ingelman-Sundberg,

Mechanisms of chronic fialuridine hepatotoxicity as revealed in primary human hepatocyte spheroids,

Toxicol Sci

(2019).

[41] J.C. Fernandez-Checa, P. Bagnaninchi, H. Ye, P. Sancho-Bru, J.M. Falcon-Perez, F. Royo, C. GarciaRuiz, O. Konu, J. Miranda, O. Lunov, Advanced preclinical models for evaluation of drug-induced liver

injury–consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET],

Journal of Hepatology 75(4) (2021) 935-959.

[42] D.G. Nguyen, J. Funk, J.B. Robbins, C. Crogan-Grundy, S.C. Presnell, T. Singer, A.B. Roth, Bioprinted

3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity in vitro,

PloS one 11(7) (2016) e0158674.

[43] S.S. Bale, S. Geerts, R. Jindal, M.L. Yarmush, Isolation and co-culture of rat parenchymal and nonparenchymal liver cells to evaluate cellular interactions and response, Sci Rep 6 (2016) 25329.

[44] A. Baze, C. Parmentier, D.F.G. Hendriks, T. Hurrell, B. Heyd, P. Bachellier, C. Schuster, M. IngelmanSundberg, L. Richert, Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and

Coculture with Nonparenchymal Cells, Tissue Eng Part C Methods 24(9) (2018) 534-545.

[45] Y.B. Kang, T.R. Sodunke, J. Lamontagne, J. Cirillo, C. Rajiv, M.J. Bouchard, M. Noh, Liver sinusoid

on a chip: Long-term layered co-culture of primary rat hepatocytes and endothelial cells in microfluidic

platforms, Biotechnol Bioeng 112(12) (2015) 2571-82.

[46] P. Paixão, L.F. Gouveia, J.A. Morais, Prediction of the human oral bioavailability by using in vitro and

in silico drug related parameters in a physiologically based absorption model, International journal of

pharmaceutics 429(1-2) (2012) 84-98.

[47] T. Hou, Y. Li, W. Zhang, J. Wang, Recent developments of in silico predictions of intestinal absorption

and oral bioavailability, Combinatorial Chemistry & High Throughput Screening 12(5) (2009) 497-506.

[48] S. Harloff-Helleberg, L.H. Nielsen, H.M. Nielsen, Animal models for evaluation of oral delivery of

biopharmaceuticals, Journal of Controlled Release 268 (2017) 57-71.

[49] S.M. Badr-Eldin, H.M. Aldawsari, S. Kotta, P.K. Deb, K.N. Venugopala, Three-Dimensional In Vitro

34

Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects, Pharmaceuticals

15(8) (2022) 926.

[50] T. Inagaki, M. Choi, A. Moschetta, L. Peng, C.L. Cummins, J.G. McDonald, G. Luo, S.A. Jones, B.

Goodwin, J.A. Richardson, Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile

acid homeostasis, Cell metabolism 2(4) (2005) 217-225.

[51] Y.I. Wang, C. Oleaga, C.J. Long, M.B. Esch, C.W. McAleer, P.G. Miller, J.J. Hickman, M.L. Shuler,

Self-contained, low-cost Body-on-a-Chip systems for drug development, Exp Biol Med (Maywood)

242(17) (2017) 1701-1713.

35

...